Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07434635 · ClinicalTrials.gov registry record · Phase 4
APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
A Phase 4 study of Eye Disorders, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT07434635: Recruiting Phase 4 study of Eye Disorders, sponsored by University of California, San Francisco.
NCT07434635 is a Phase 4 study of Eye Disorders that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 62 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07434635, a Phase 4 study of Eye Disorders, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
Primary Outcome
Whether atropine use impacts post-operative pain score on the standard Visual Analog Scale (VAS)
Conditions Studied
Interventions
- DRUG Atropine 1%
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2026-02 |
| Est. Completion | 2029-02 |
| Phase | Phase 4 |
What NCT07434635 shows while recruiting
NCT07434635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Eye Disorders appearing as the primary indexed condition, and to 1 intervention - of which Atropine 1% is the first listed.
NCT07434635 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07434635 about?
NCT07434635 is a clinical study titled "APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes". The study will evaluate whether atropine eyedrops are beneficial when used after certain eye surgeries.
What is the current status of trial NCT07434635?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2026-02. Estimated completion is 2029-02.
What conditions does trial NCT07434635 study?
This clinical trial studies the following conditions: Eye Disorders.
What interventions are being tested in trial NCT07434635?
The interventions under investigation include: Atropine 1% (DRUG).
Who is sponsoring clinical trial NCT07434635?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07434635 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07434635's enrollment target sits among peer trials
62 1110th of 2000 higher than 883 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia